Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: A population-based study

JACC: Cardiovascular Interventions

Volumn 4, Issue 9, 2011, Pages 965-973

  Ko, Dennis T ^a,b   Guo, Helen ^b   Wijeysundera, Harindra C ^a   Zia, Mohammad I ^a   Davík, Vladimír ^a   Chu, Michael W A ^c   Fremes, Stephen E ^a   Cohen, Eric A ^a   Tu, Jack V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

death; drug eluting stents; myocardial infarction; saphenous vein graft; target vessel revascularization

Indexed keywords

PACLITAXEL;

ADULT; AGED; ARTICLE; BARE METAL STENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEVICE SAFETY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REOPERATION; REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; VEIN GRAFT DISEASE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053048011     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.06.009     Document Type: Article

References (25)

1. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
2. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
3. M.N. Babapulle, L. Joseph, P. Bélisle, J.M. Brophy, and M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591 (Pubitemid 39094175)
4. J.A. Bittl Drug-eluting stents for saphenous vein graft lesions: the limits of evidence J Am Coll Cardiol 53 2009 929 930
5. J.S. Douglas Jr Are our patients better off with drug-eluting stents in saphenous vein grafts? J Am Coll Cardiol Intv 2 2009 1113 1115
6. P. Vermeersch, P. Agostoni, and S. Verheye Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial J Am Coll Cardiol 48 2006 2423 2431 (Pubitemid 44895571)
7. P. Vermeersch, P. Agostoni, S. Verheye DELAYED RRISC Investigators Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial J Am Coll Cardiol 50 2007 261 267 (Pubitemid 47039289)
8. E.S. Brilakis, C. Lichtenwalter, and A.-R. Abdel-karim Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) Trial J Am Coll Cardiol Intv 4 2011 176 182
9. B.R. Brodie, H. Wilson, T. Stuckey STENT Group Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group J Am Coll Cardiol Intv 2 2009 1105 1112
10. N.J. Goswami, M. Gaffigan, and G. Berrio Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry Catheter Cardiovasc Interv 75 2010 93 100
11. A. Latib, L. Ferri, and A. Ielasi Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts Circ Cardiovasc Interv 3 2010 249 256
12. P. Meier, E.S. Brilakis, R. Corti, G. Knapp, M.H. Shishehbor, and H.S. Gurm Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis PLoS ONE 5 2010 e11040
13. J.M. Paradis, P. Bélisle, and L. Joseph Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis Circ Cardiovasc Interv 3 2010 565 576
14. M.E. Wiisanen, A. Abdel-Latif, D. Mukherjee, and K.M. Ziada Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis J Am Coll Cardiol Intv 3 2010 1262 1273
15. M. Egger, M. Schneider, and G. Davey Smith Spurious precision? Meta-analysis of observational studies BMJ 316 1998 140 144 (Pubitemid 28121116)
16. R.J. Applegate, M. Sacrinty, M. Kutcher, R. Santos, S. Gandhi, and W. Little Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis Catheter Cardiovasc Interv 72 2008 7 12 (Pubitemid 352013502)
17. D.T. Ko, M. Chiu, and H. Guo Safety and Effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications J Am Coll Cardiol 53 2009 1773 1782
18. J.V. Tu, J. Bowen, and M. Chiu Effectiveness and safety of drug-eluting stents in Ontario N Engl J Med 357 2007 1393 1402 (Pubitemid 47541971)
19. P.C. Austin, and M.M. Mamdani A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use Stat Med 25 2006 2084 2106 (Pubitemid 43950281)
20. P.C. Austin, M.M. Mamdani, T.A. Stukel, G.M. Anderson, and J.V. Tu The use of the propensity score for estimating treatment effects: administrative versus clinical data Stat Med 24 2005 1563 1578 (Pubitemid 40716354)
21. M.P. Savage, J.S. Douglas Jr., D.L. Fischman Saphenous Vein de Novo Trial Investigators Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med 337 1997 740 747 (Pubitemid 27417973)
22. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: the SOS (Stenting of Saphenous Vein Grafts) Trial J Am Coll Cardiol 53 2009 919 928
23. J. Mehilli, G. Richardt, and F.J. Neumann Long-Term Outcomes after Use of Drug-Eluting Stents and Bare Metal Stents for the Treatment of Saphenous Vein Graft Lesions: Results of the Randomized ISAR-CABG Trial Paper presented at: ACC.11 & i2 Summit; April 4, 2011; New Orleans, LA http://www.cardiosource. org/acc11coverage Accessed May 1, 2011
24. S.G. Ellis, S.J. Brener, and S. DeLuca Late myocardial ischemic events after saphenous vein graft interventionimportance of initially "nonsignificant" vein graft lesions Am J Cardiol 79 1997 1460 1464 (Pubitemid 27251063)
25. D.T. Ko, M. Chiu, H. Guo, P.C. Austin, J.F. Marquis, and J.V. Tu Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Am Heart J 158 2009 592 598 e1